Understanding the Transition from Normal Melanocytes to Nevus to Melanoma

NCT06605417 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-02-27

No results posted yet for this study

Summary

The primary objective of this study is to identify the molecular identity profiles of all cellular states that characterize the progression from benign nevi to malignant melanoma in CAYA patients with L/GCMN. The secondary objectives are:

* To longitudinally characterize the cell-free DNA (cfDNA) from CAYA patients.
* To improve the early diagnosis and treatments for intermediate conditions such as L/GCMN through evidence-based interpretation of personal risk from endogenous or exogenous sources.
* To test pre-clinical strategies to best model and improve patient response.

Conditions

  • Congenital Melanocytic Nevi
  • Melanoma, Skin
  • Nevi and Melanomas

Interventions

GENETIC

Methylomics

Methylomics analysis of FFPE blocks and frozen tissues

GENETIC

RNA sequencing

RNA sequencing of FFPE blocks and frozen tissues

GENETIC

Spatial transcriptomics

Spatial transcriptomics of FFPE blocks and frozen tissues

GENETIC

Liquid biopsy

cfDNA characterization extracted from blood/saliva

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator UNKNOWN
  • University Hospital Tuebingen

    collaborator OTHER
  • University of Florence

    collaborator OTHER
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER
  • University Of Perugia

    collaborator OTHER
  • German Cancer Research Center

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Maria Sklodowska-Curie National Research Institute of Oncology

    collaborator OTHER
  • Institut Curie

    collaborator OTHER
  • Medical University of Gdansk

    collaborator OTHER
  • Princess Maxima Center for Pediatric Oncology

    collaborator OTHER
  • Institut Català d'Oncologia

    collaborator OTHER
  • Fundacion Clinic per a la Recerca Biomédica

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-03-31
Completion
2026-11-30

Countries

  • France
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06605417 on ClinicalTrials.gov